Consumer Goods Companies Make 'Significant Improvement' in Sup... - 07 March 2019 02:38

PARIS, Mar. 7, 2019 /PRNewswire-AsiaNet/-- - Consumer goods retailers and manufacturers' participation in food banks and school programmes continues to rise - 320,000 products have been reformulated to reduce levels of sugar and salt, etc, since survey began in 2015 - Some 2,0...

  GFSI Conference 2019 Showcases Leadership and Innovation in th... - 06 March 2019 09:47

NICE, France, March 6, 2019 /PRNewswire-AsiaNet/-- The 2019 GFSI Conference, organised by The Consumer Goods Forum's Global Food Safety Initiative [https://www.mygfsi.com ] (GFSI), came to a successful close last week with more than 1000 delegates from the food industry, government and acad...

  Ozempic(R)Superior in Lowering Blood Sugar and Weight Vs Place... - 05 March 2019 00:00

BAGSVAERD, Denmark, March 5, 2019 /PRNewswire-AsiaNet/ -- Novo Nordisk today announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was to assess the efficacy and safety of Ozempic(R) (semaglutide) 1.0 mg when add...

  Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For th... - 05 March 2019 00:00

PLYMOUTH MEETING, PA., Mar. 5, 2019 /PRNewswire-AsiaNet/-- -- The second Phase 3 study initiation announcement made during the International HPV Awareness Day Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the initiation and opening of sites to enroll the second portion of the company's Pha...

  Merck Awarded Canadian CRISPR Nickase Patent for Foundational ... - 05 March 2019 00:00

DARMSTADT, Germany, March 5, 2019 /PRNewswire-AsiaNet/ -- -- Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects -- Marks company's 13th CRISPR patent overall -- Actively licensing CRISPR-related patents to interested parties Merck ( https...

  AGC Completes Acquisition of Spanish Synthetic Pharmaceutical ... - 04 March 2019 17:00

TOKYO, Mar. 4, 2019 /Kyodo JBN - AsiaNet/ -- AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC). The transaction had been previous...

  Candela Unveils New Corporate Identity at the 2019 American Ac... - 02 March 2019 12:00

WAYLAND, Mass., March 2, 2019 /PRNewswire-AsiaNet/ -- -- New brand reflects commitment to Science, Results, Trust Syneron-Candela, a leading global medical aesthetic device company, announced today that it has rebranded the company to Candela and will be unveiling new corporate branding at ...

  Galderma: New Data Reveals Benefits of Combining Oral and Topi... - 01 March 2019 23:25

LAUSANNE, Switzerland, Mar. 1, 2019 /PRNewswire-AsiaNet/-- First randomized clinical trial comparing the efficacy and safety of combined doxycycline 40 mg modified release (DMR) and ivermectin 1% cream (IVM), versus ivermectin 1% cream plus placebo in adults with severe papulopustular rosacea, reveals mor...

  Rakuten Aspyrian Announces Name Change to Rakuten Medical - 01 March 2019 17:09

SAN MATEO, Calif., Mar. 1, 2019 /PRNewswire-AsiaNet/-- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced that it has changed its name to Rakuten Medical, Inc. This name more closely reflects th...

  Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalte... - 01 March 2019 10:15

SINGAPORE, March 1, 2019 /PRNewswire-AsiaNet/ -- Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies targeting solid tumors, today announced the appointment of Mr. Jeffrey H. Buchalter as an independent director. Mr. Buchalt...